Zoetis Q4 FY25: where the revenue came from and where it went
The whole income statement of Zoetis for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 1 – Dec 31, 2025
- Reported
- Feb 12, 2026
Revenue$2.41B
+4% year over year
Gross profit$1.69B
70% margin
Operating profit$0.79B
33% margin
Net profit$0.63B
26% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 2.41 | 100% | +4% |
| Parasiticides | 0.54 | 22% | |
| Vaccines | 0.51 | 21% | |
| Dermatology | 0.43 | 18% | |
| Anti infective products | 0.28 | 12% | |
| Other revenue | 0.21 | 9% | |
| Other pharmaceuticals | 0.19 | 8% | |
| Swine | 0.13 | 5% | |
| Poultry | 0.12 | 5% | |
| Cost of revenue | −0.72 | 30% | |
| Gross profit | 1.69 | 70% margin | +1pp |
| SG&A | −0.61 | 25% | −2pp |
| Other | −0.30 | 13% | +0pp |
| Operating profit | 0.79 | 33% margin | +2pp |
| Tax | −0.15 | ||
| Net profit | 0.63 | 26% margin | +1pp |
98 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest